2023
DOI: 10.1016/j.biopha.2023.115013
|View full text |Cite
|
Sign up to set email alerts
|

Advances in microneedle-based therapy for bone disorders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 47 publications
0
2
0
Order By: Relevance
“…Bone diseases are a recurring problem in the general population and are presented in diverse ways leading to mass bone loss [ 1 ]. New treatments are studied to solve this problem with less collateral effect and good efficacy [ 31 ]. In this way, we hypothesize that a new formulation of HT-NE may permit a controlled release of HT and provide safe treatment techniques, in addition to enhancing its biocompatibility and biological activities.…”
Section: Discussionmentioning
confidence: 99%
“…Bone diseases are a recurring problem in the general population and are presented in diverse ways leading to mass bone loss [ 1 ]. New treatments are studied to solve this problem with less collateral effect and good efficacy [ 31 ]. In this way, we hypothesize that a new formulation of HT-NE may permit a controlled release of HT and provide safe treatment techniques, in addition to enhancing its biocompatibility and biological activities.…”
Section: Discussionmentioning
confidence: 99%
“…In an attempt to mimic the physiology of bone, various morphologies of silk fibroin have been investigated for the delivery of bone specific growth factors (such as BMP-2, platelet-derived growth factors), with a crucial role in promoting osteogenesis for the application in bone regeneration [82]. In the prevention and management of bone-related disorders, despite the progress of the conventional drug delivery systems, the limited drug absorption and lack of specificity in therapeutic outcomes have encouraged the use of microneedle-based therapy as a safe and well-tolerable therapeutic approach [83]. For example, a composite microneedles system consisting of silk fibroin needle tips and a hyaluronic acid base has been developed by Li et al for the transdermal delivery of salmon calcitonin for the treatment of osteoporosis.…”
Section: Applications Of Silk Fibroin In Ddssmentioning
confidence: 99%